About
Technology
Issues
FAQ
Links
Official Page
A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.